Fiscal year is July-June. All values USD millions.	2012	2013	2014	2015	2016	5-year trend
Sales/Revenue	73.75B	77.65B	86.73B	92.97B	84.7B
Cost of Goods Sold (COGS) incl. D&A	17.53B	20.25B	26.93B	33.04B	32.78B
COGS excluding D&A	14.56B	16.49B	21.72B	27.08B	26.16B
Depreciation & Amortization Expense	2.97B	3.76B	5.21B	5.96B	6.62B
Depreciation	2.29B	2.81B	4.17B	4.58B	5.58B
Amortization of Intangibles	675M	949M	1.05B	1.38B	1.05B
Gross Income	56.22B	57.41B	59.8B	59.93B	51.92B

	2012	2013	2014	2015	2016	5-year trend
SG&A Expense	28.24B	30.84B	32.01B	32.37B	31.25B
Research & Development	9.81B	10.41B	11.38B	12.05B	11.99B
Other SG&A	18.43B	20.43B	20.63B	20.32B	19.26B
Other Operating Expense	-	-	-	-	-
Unusual Expense	6.86B	404M	561M	10.62B	1.88B
EBIT after Unusual Expense	21.13B	26.17B	27.22B	16.95B	18.79B
Non Operating Income/Expense	719M	639M	313M	1.58B	1.3B
Non-Operating Interest Income	800M	677M	883M	766M	903M
Equity in Affiliates (Pretax)	-	-	-	-	-
Interest Expense	380M	429M	597M	781M	1.24B
Gross Interest Expense	380M	429M	597M	781M	1.24B
Interest Capitalized	-	-	-	-	-
Pretax Income	22.27B	27.05B	27.82B	18.51B	19.75B
Income Tax	5.29B	5.19B	5.75B	6.31B	2.95B
Income Tax - Current Domestic	2.39B	3.46B	4B	4.03B	681M
Income Tax - Current Foreign	1.95B	1.75B	2.07B	2.07B	1.94B
Income Tax - Deferred Domestic	954M	(19M)	(331M)	224M	332M
Income Tax - Deferred Foreign	-	-	-	-	-
Income Tax Credits	-	-	-	-	-
Equity in Affiliates	-	-	-	-	-
Other After Tax Income (Expense)	-	-	-	-	-
Consolidated Net Income	16.98B	21.86B	22.07B	12.19B	16.8B
Minority Interest Expense	-	-	-	-	-
Net Income	16.98B	21.86B	22.07B	12.19B	16.8B
Extraordinaries & Discontinued Operations	-	-	-	-	-
Extra Items & Gain/Loss Sale Of Assets	-	-	-	-	-
Cumulative Effect - Accounting Chg	-	-	-	-	-
Discontinued Operations	-	-	-	-	-
Net Income After Extraordinaries	16.98B	21.86B	22.07B	12.19B	16.8B
Preferred Dividends	-	-	-	-	-
Net Income Available to Common	16.98B	21.86B	22.07B	12.19B	16.8B
EPS (Basic)	2.02	2.61	2.66	1.49	2.12
Basic Shares Outstanding	8.4B	8.38B	8.3B	8.18B	7.93B
EPS (Diluted)	2.00	2.58	2.63	1.48	2.10
Diluted Shares Outstanding	8.51B	8.47B	8.4B	8.25B	8.01B
EBITDA	30.95B	30.32B	32.99B	33.52B	27.29B

2] Applying common size on income statement (please do not use consistent year -- if you use 2014, the second year should be 2016.

3] Applying comparative analysis on balance with two years

4] Create the statement of cash flow with indirect method based on the information from your calculation on balance sheet

5] provide two ratios related a company

6] Interpretation on each statement - income statement; balance sheet and statement of cashflow

7] interpretation on each ratio

8] conclusion.